Use of Virtual Reality for Surgical Planning in Neuroblastoma (VRNB)
Neuroblastoma
About this trial
This is an interventional treatment trial for Neuroblastoma focused on measuring virtual reality, neuroblastoma, surgery, planning, cancer, childhood
Eligibility Criteria
Inclusion Criteria: Pediatric patients (0-18 years) with neuroblastoma in L1, L2 or M stages (INGRSS) who have surgical indication for resection. Exclusion Criteria: Patients with relapsed neuroblastoma. Patients with neuroblastoma other than abdominal or pelvic location. Patients with previous surgery for the current diagnosis of neuroblastoma (excluding the biopsy that made the diagnosis). Patients who have undergone laparoscopic surgery. Patients operated on by a surgical team other than the one that usually treats oncology children at your center. Failure to obtain informed consent. Lack of complete medical records.
Sites / Locations
- Hospital Sant Joan de DéuRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Group A
Group B
Patients with L1, L2 or M INRGSS neuroblastoma in which their surgical planning will be performed using gold standard imaging (TC and/or MRI) and immersive virtual reality HMD device.
Patients with L1, L2 or M INRGSS neuroblastoma in which their surgical planning will be performed using only gold standard imaging (TC and/or MRI)